Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • الموضوع:
      2013
    • Collection:
      DI-fusion : dépôt institutionnel de l'Université libre de Bruxelles (ULB)
    • نبذة مختصرة :
      The role of circulating tumor cells (CTCs) in HER2-positive breast cancer patients receiving neoadjuvant therapy is unclear. ; Journal Article ; Research Support, Non-U.S. Gov't ; SCOPUS: ar.j ; info:eu-repo/semantics/published
    • File Description:
      2 full-text file(s): application/pdf | application/pdf
    • Relation:
      uri/info:doi/10.1016/j.breast.2013.08.014; uri/info:pii/S0960-9776(13)00248-8; uri/info:pmid/24060577; uri/info:scp/84887201080; https://dipot.ulb.ac.be/dspace/bitstream/2013/157832/3/Elsevier_142939.pdf; https://dipot.ulb.ac.be/dspace/bitstream/2013/157832/6/doi_142939.pdf; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/157832
    • الدخول الالكتروني :
      http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/157832
      https://dipot.ulb.ac.be/dspace/bitstream/2013/157832/3/Elsevier_142939.pdf
      https://dipot.ulb.ac.be/dspace/bitstream/2013/157832/6/doi_142939.pdf
    • الرقم المعرف:
      edsbas.CEF20D01